Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2024

Houston, TX US
September 21, 2024

In-Person and Virtual attendance options are available. 

Presented by the Sherrie and Alan Conover Center for Liver Disease & Transplantation at Houston Methodist

The epidemic of liver disease has become increasingly more common and poses complex problems regarding diagnosis and management. There are recent advances in the diagnosis and management of patients with liver disease. This CE activity has been designed to educate attendees about new developments in hepatology, and new approaches to management of liver diseases that can be readily integrated into their daily practice. A group of national experts, including several renowned guest faculty, will present new findings in a clinical context that will be beneficial in the multidisciplinary management of unique and complex liver disorders.

This course, in addition to lecture format presentations, will provide interactive instructional presentations, debate and panel discussions, Q&A sessions, case discussions and use an interactive audience response system

.​​​​​FEES

REGISTRATION TYPEFEE
Physician (Houston Methodist)$25
Physician (Private physician located within the Greater Houston Area)*$300
Physician (Private physician located outside the Greater Houston Area)$50
Allied Health Care Professional (including Nurses)$10
Resident / Fellow / StudentComplimentary

* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.

Target Audience

This conference is designed for primary care physicians, internists, hepatologists, gastroenterologists, oncologists, nurses, nurse practitioners, and physician assistants and other health care providers.

Learning Objectives

At the conclusion of this activity, the participant should be able to: 

  • Discuss the current trends in Liver Disease.
  • Describe new and critical developments in chronic HBV, HCV and HDV. 
  • Identify emerging trends in the obesity crisis & nonalcoholic fatty liver disease and explore the latest concepts in diagnosis and management.
  • Discuss new developments and treatment of liver and pancreatic cancers – an emerging epidemic.
Course summary
Available credit: 
  • 7.75 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 7.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 7.75 Attendance
  • 7.75 Nursing Contact Hours

    Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Houston Methodist will award 7.75 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.

  • 7.75 Social Work
    The program has been approved for 7.75 CE contact hours for Social Workers through the Texas State Board of Social Work Examiners.
  • 7.75 Transplant Coordinators
    The American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2024 | Sun, 05/26/2024 - 8:00am | 7.75 Category 1 CEPTCs
Course opens: 
05/26/2024
Course expires: 
10/21/2024
Event starts: 
09/21/2024 - 7:30am CDT
Event ends: 
09/21/2024 - 5:00pm CDT
Cost:
$300.00
Emerging Topics in Liver Disease Conference:
Innovative Trends in Liver Health 2024
AGENDA | Saturday, September 21
TIMEPRESENTATIONSPEAKER(S)
7:00 AMRegistration and Breakfast
7:30 AMConference WelcomeVictor Ankoma-Sey, MD
PLENARY SESSION I
Alcoholic Liver Disease - An Update
Moderators: Joseph Galati, MD, Chukwuma Egwim, MD 
7:40 AMAlcohol Use Disorder and Alcohol Associated Liver Disease -
Evolving Definitions, Diagnosis & Epidemiology
Kavish R. Patidar, MD
8:10 AMState of the Art Lecture I
Alcohol Associated Liver Disease: Current & Future Therapies
Juan Pablo Arab, MD
8:40 AMAlcohol Associated Liver Disease & Liver TransplantationAshish Saharia, MD
9:05 AMQ&A and Discussion 
9:20 AMBREAK
PLENARY SESSION II
Current Innovations in the Management of Unique Liver Diseases

Moderators: Tamneet Basra, MD, Caroline Simon, MD, Andrea Duchini, MD
9:35 AMState of the Art Lecture II
Genetic Liver Diseases in adults (Hemochromatosis, Wilson’s, Alpha-1-antitrypsin deficiency): What do we know in 2024?
Michael Schilsky, MD
10:05 AMDrug induced Liver Injury - An UpdateDavid E. Bernstein, MD
10:35 AMChronic Viral Hepatitis B: Can we expect a Cure?Michelle Jones-Pauley, MD
11:05 AMChronic Viral Hepatitis C Elimination: Obstacles & OpportunitiesNorah A. Terrault, MD
11:35 AMQ&A and Discussion
11:50 AMLUNCH 
12:05 PMPRODUCT THEATRE (Presented in Boardroom)
MASLD: An Overview
*Not certified for CE credit
Mazen Nourreddin, MD, MHSc
PLENARY SESSION III
Metabolic Dysfunction - Associated Fatty liver Disease (MASLD) - What is New?

Moderators: Victor Ankoma-Sey, MD, David Victor, MD & Constance Mobley, MD
12:50 PMApproaches for MASLD to dampen its public health impact going forwardW. Ray Kim, MD
1:20 PMPractical Use of Noninvasive Tests in the Diagnosis & Management of  MASLD patientsNaim Alkhouri, MD, FAASLD
1:50 PMState of the Art Lecture III
Current and Future Treatment Options in MASLD
David Victor, MD
2:20 PMRole of Artificial Intelligence (AI) in the Management of MASLD?Vlad Ratziu, MD
2:50 PMQ&A and Discussion
3:05 PMBREAK
PLENARY SESSION IV
Liver Cancers: Hepatocellular Carcinoma & Cholangiocarcinoma - Current Concepts & Controversies

Moderators: Sudha Kodali, MD, MSPH, Maen Abdelrahim, MD, PhD, B Pharm & Kirk Heyne, MD
3:20 PMEvolving Epidemiology of Hepatocellular Cancer & CholangiocarcinomaAshton Connor, MD
3:50 PMState of the Art Lecture IV
Management of Hepatocellular carcinoma & Cholangiocarcinoma -
Role of immunotherapy & Ablative Therapies
Ahmed Kaseb, MD
4:20 PMLiver Transplantation for Hepatocellular Cancer & Cholangiocarcinoma – Current Approach & ControversiesSudha Kodali, MD
4:45 PMQ&A and Discussion
5:00 PMCONCLUDING REMARKS
Houston Methodist (In-Person and Virtual attendance options are available).
6670 Bertner Avenue
John F. Bookout Auditorium, 2nd Floor
Houston, TX 77030
United States

In-Person attendance will be held in the Houston Methodist Research Institute (6670 Bertner Avenue, Houston, Texas 77030). 

Virtual information will be provided to registered learners. 

COURSE DIRECTOR
Victor Ankoma-Sey, MD, FACP, FAASLD
Director, Liver Transplant Program
Sherrie and Alan Conover Center for Liver Disease & Transplantation
Houston Methodist J.C. Walter Jr. Transplant Center
Director, Liver Associates of Texas, PA

Available Credit

  • 7.75 AMA PRA Category 1 Credit

    Houston Methodist is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    Houston Methodist designates this Live activity for a maximum of 7.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

  • 7.75 Attendance
  • 7.75 Nursing Contact Hours

    Houston Methodist is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

    Houston Methodist will award 7.75 Nursing Continuing Professional Development contact hours for this activity. Participants must attend the activity in its entirety and complete the continuing education evaluation.

  • 7.75 Social Work
    The program has been approved for 7.75 CE contact hours for Social Workers through the Texas State Board of Social Work Examiners.
  • 7.75 Transplant Coordinators
    The American Board for Transplant Certification (ABTC) has assigned the following Continuing Education Points for Transplant Certification (CEPTCs) to the following Houston Methodist Transplant Center educational program: Emerging Topics in Liver Disease Conference: Innovative Trends in Liver Health 2024 | Sun, 05/26/2024 - 8:00am | 7.75 Category 1 CEPTCs

Interested in exhibiting? Contact us for more information.

Price

Cost:
$300.00
Please login or register to take this course.

REGISTRATION INSTRUCTIONS

  • STEP 1 - Choose the activity format you would like to attend (LIVE or LIVESTREAM) by selecting the checkbox next to the activity and clicking the "Enroll" button. 
  • STEP 2 - Once enrolled, click the link of the activity format for which you enrolled (the Status should say "In progress") and then click the "Take Course" button to begin the activity.

FEES

REGISTRATION TYPEFEE
Physician (Houston Methodist)$25
Physician (Private physician located within the Greater Houston Area)*$300
Physician (Private physician located outside the Greater Houston Area)$50
Allied Health Care Professional (including Nurses)$10
Resident / Fellow / StudentComplimentary

* In compliance with HM’s policy on Physician Non-Monetary Compensation regarding “Stark Law,” private physicians who reside and/or practice medicine within the Greater Houston Area are required to pay the full Fair Market Value registration fee.